Sargent Bickham Lagudis’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.18K Hold
50
﹤0.01% 958
2022
Q3
$1K Sell
50
-58
-54% -$2.04K ﹤0.01% 948
2022
Q2
$4K Buy
108
+17
+19% +$722 ﹤0.01% 838
2022
Q1
$7K Hold
91
﹤0.01% 759
2021
Q4
$8K Buy
91
+50
+122% +$5.98K ﹤0.01% 749
2021
Q3
$5K Sell
41
-89
-68% -$13K ﹤0.01% 813
2021
Q2
$22K Hold
130
﹤0.01% 597
2021
Q1
$24K Buy
130
+4
+3% +$928 ﹤0.01% 562
2020
Q4
$25K Hold
126
﹤0.01% 528
2020
Q3
$28K Buy
126
+71
+129% +$15K ﹤0.01% 464
2020
Q2
$10K Sell
55
-27
-33% -$4.73K ﹤0.01% 586
2020
Q1
$13K Buy
+82
New +$9.54K ﹤0.01% 524

Other funds holding TDOC

Sargent Bickham Lagudis's TDOC Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Teladoc Health (TDOC) position steady in Q4 2022 at 50 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Sargent Bickham Lagudis first reported a position in TDOC in Q1 2020 and has held it in 12 quarters since. The position peaked at $28K in Q3 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Sargent Bickham Lagudis held 50 shares of Teladoc Health worth $1.18K as of Q4 2022.
  • Sargent Bickham Lagudis left its Teladoc Health share count unchanged in Q4 2022.
  • Teladoc Health made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #958 holding.
  • Sargent Bickham Lagudis first reported a position in Teladoc Health in Q1 2020 and has held it in 12 quarters since.
  • Sargent Bickham Lagudis's Teladoc Health position peaked at $28K in Q3 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.